FI951009A0 - Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä - Google Patents

Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä

Info

Publication number
FI951009A0
FI951009A0 FI951009A FI951009A FI951009A0 FI 951009 A0 FI951009 A0 FI 951009A0 FI 951009 A FI951009 A FI 951009A FI 951009 A FI951009 A FI 951009A FI 951009 A0 FI951009 A0 FI 951009A0
Authority
FI
Finland
Prior art keywords
diarylpiperazinoacetamide
compounds useful
antimuscarinic agents
antimuscarinic
agents
Prior art date
Application number
FI951009A
Other languages
English (en)
Swedish (sv)
Other versions
FI951009A (fi
Inventor
Hijfte Luc Van
Mary Richards
Marcel Hibert
Jan Hoflack
Susanne Trumpp-Kallmeyer
Gilbert Marciniak
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI951009A0 publication Critical patent/FI951009A0/fi
Publication of FI951009A publication Critical patent/FI951009A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951009A 1992-09-04 1995-03-03 Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä FI951009A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92402435A EP0585500A1 (en) 1992-09-04 1992-09-04 Diaryl piperazineacetamides as antimuscarinic agents
PCT/US1993/007198 WO1994005648A1 (en) 1992-09-04 1993-07-29 Diaryl piperazinoacetamide compounds as antimuscarinic agents

Publications (2)

Publication Number Publication Date
FI951009A0 true FI951009A0 (fi) 1995-03-03
FI951009A FI951009A (fi) 1995-03-03

Family

ID=8211704

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951009A FI951009A (fi) 1992-09-04 1995-03-03 Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä

Country Status (12)

Country Link
EP (2) EP0585500A1 (fi)
JP (1) JPH08501096A (fi)
AU (1) AU668413B2 (fi)
CA (1) CA2143744A1 (fi)
FI (1) FI951009A (fi)
HU (1) HUT71890A (fi)
IL (1) IL106878A0 (fi)
MX (1) MX9305248A (fi)
NZ (1) NZ255176A (fi)
TW (1) TW281674B (fi)
WO (1) WO1994005648A1 (fi)
ZA (1) ZA936362B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859295A (en) * 1994-12-05 1999-01-12 University Of Kentucky Research Foundation Canavanine analogs and their use as chemotherapeutic agents
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
GB9513972D0 (en) * 1995-07-08 1995-09-06 Merck Sharp & Dohme Pharmaceutical compositions
CN1244542C (zh) * 1996-12-24 2006-03-08 中外制药株式会社 具有nos抑制作用的芳香族胺衍生物
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
WO1999005095A1 (fr) * 1997-07-24 1999-02-04 Mitsubishi-Tokyo Pharmaceuticals, Inc. Composes d'aminocycloalcane
WO1999052892A2 (en) * 1998-04-08 1999-10-21 Novartis Ag Novel herbicides
US6511980B2 (en) 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
AU2003214800A1 (en) 2002-01-02 2003-07-24 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
FR2840609A1 (fr) * 2002-06-05 2003-12-12 Lipha Derives nitroso de la diphenylamine, compositions les contenant et leur utilisation en tant qu'antioxydants et donneurs spontanes d'oxyde nitrique
JP2006508061A (ja) * 2002-09-20 2006-03-09 ファイザー・プロダクツ・インク エストロゲン受容体に対するアミドおよびスルホンアミドリガンド
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
US9040558B2 (en) 2004-12-31 2015-05-26 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
GB0815781D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
WO2011000945A2 (en) 2009-07-03 2011-01-06 Nensius Research A/S Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
CA2845284C (en) 2011-08-18 2018-03-06 Dr. Reddy's Laboratories Ltd. Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors
EP2760864B1 (en) 2011-09-27 2018-01-24 Dr. Reddy's Laboratories Ltd. 5-BENZYLAMINOMETHYL-6-AMINOPYRAZOLO[3,4-b]PYRIDINE DERIVATIVES AS CHOLESTERYL ESTER-TRANSFER PROTEIN (CETP) INHIBITORS USEFUL FOR THE TREATMENT OF ATHEROSCLEROSIS
CA3021062A1 (en) * 2016-04-15 2017-10-19 Epizyme, Inc. Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
WO2018195450A1 (en) 2017-04-21 2018-10-25 Epizyme, Inc. Combination therapies with ehmt2 inhibitors
TW202241856A (zh) * 2020-12-28 2022-11-01 日商塩野義製藥股份有限公司 具有血清素受體結合活性之環狀胺衍生物
CN117980302A (zh) * 2021-08-10 2024-05-03 德克萨斯心脏研究所 Lfa-1和vla-4的基于哌嗪的激动剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209723B (en) * 1990-10-31 1994-10-28 Richter Gedeon Vegyeszet Process for producing of piperazine derivatives
US5276155A (en) * 1991-12-20 1994-01-04 G. D. Searle & Co. Process for the resolution of (±)-α-[2-[acetyl(1-methylethyl)amino]ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide
DE4314962A1 (de) * 1993-05-06 1994-11-10 Bayer Ag Substituierte Piperazine

Also Published As

Publication number Publication date
ZA936362B (en) 1994-03-28
NZ255176A (en) 1996-02-27
AU668413B2 (en) 1996-05-02
JPH08501096A (ja) 1996-02-06
AU4795393A (en) 1994-03-29
EP0658157A1 (en) 1995-06-21
TW281674B (fi) 1996-07-21
CA2143744A1 (en) 1994-03-17
EP0585500A1 (en) 1994-03-09
IL106878A0 (en) 1993-12-28
HUT71890A (en) 1996-02-28
WO1994005648A1 (en) 1994-03-17
HU9500664D0 (en) 1995-04-28
MX9305248A (es) 1995-01-31
FI951009A (fi) 1995-03-03

Similar Documents

Publication Publication Date Title
FI951009A0 (fi) Muskariinin vastaisina aineina käyttökelpoisia diaryylipiperatsinoasetamidiyhdisteitä
FI931229A0 (fi) Som glanspigment laempade blandningar
BR1101108A (pt) Composto
DE69405554T2 (de) Peroxysaeure
IT1271014B (it) 3-aril-benzofuranoni come agenti stabilizzanti
FI944804A (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
FI931069A (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
BR9300260A (pt) Composicao detergente estavel
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
ID1052B (id) Komposisi deterjen
DE69319158T2 (de) Waschmittelzusammensetzung
DE69304715T2 (de) Waschmittelzusammensetzung
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
DK43192D0 (da) Detergentkomposition
DK124393D0 (da) Compounds
NO971955D0 (no) Nitro-benzamider anvendelige som anti-arrhytmiske midler
DK0660715T3 (da) Carbostyrilderivater som antiarytmiske midler
NO945074D0 (no) 17-Alkyleton-steroider anvendelige som 5- itorer
FI961520A (fi) Heribisidiset atsabisfosfonihappoyhdisteet
FI962010A0 (fi) Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja
NO950842D0 (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler
DE69314038D1 (de) Waschmittelzusammensetzung
FI935826A0 (fi) Kallsmoerjmedel med delvis neutraliserade fosforsyraestrar som EP-tillsatsaemnen
NO951299D0 (no) Polyaminderivater som anti-cytomegalovirale midler
NO962535D0 (no) Di-tert-butylfenolforbindelser anvendbare som antiflammatoriske midler